Article
Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
Bullish
65.0
−100 Bearish
0
+100 Bullish
While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Bullish
65.0
−100Neutral+100
More Like This